- Home
- / Infinity Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Infinity Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2023-12-01
Market Capitalization
$726.1 K
2023-12-01
Revenue
$2.6 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 109.1M | 18.7M | 6.0M | 22.1M | 3.0M | 1.7M | 1.9M | 2.6M | ||||
| Revenue growth, % | -33.9% | -82.8% | ||||||||||
| General and administrative expense | 22.7M | 27.9M | 27.9M | 29.3M | 37.1M | 42.2M | 21.6M | 14.2M | 14.3M | 12.4M | 14.2M | 13.5M |
| Operating expense total | 131.3M | 146.5M | 127.7M | 172.9M | 236.2M | 161.8M | 42.4M | 34.0M | 41.4M | 39.2M | 45.9M | |
| EBIT | (38.5M) | (52.8M) | (127.7M) | (7.9M) | (127.1M) | (30.9M) | (36.4M) | (11.9M) | (45.7M) | (38.5M) | (45.1M) | (44.8M) |
| EBIT margin, % | -116.5% | -165.0% | -607.4% | -53.9% | -1497.7% | -2239.5% | -1729.4% | |||||
| Investment income | 1.1M | |||||||||||
| Interest income | 326.8K | 559.0K | 896.0K | |||||||||
| Interest expense | 1.8M | 1.9M | 896.0K | 9.3M | 933.0K | 790.0K | 6.1M | 676.0K | ||||
| Pre tax profit | (40.0M) | (54.0M) | (126.8M) | (17.2M) | (128.0M) | (30.1M) | (42.5M) | (11.3M) | (47.1M) | (40.5M) | ||
| Income tax expense | 183.0K | 335.0K | (700.0K) | (100.0K) | ||||||||
| Net Income | (40.0M) | (54.0M) | (126.8M) | (17.4M) | (128.4M) | (30.1M) | (41.8M) | (11.3M) | (47.1M) | (40.5M) | (45.3M) | (44.4M) |
| EPS | (0.5) |